Catalyst Wire Dossier Catalyst Wire Dossier

CAMZYOS

MAVACAMTEN · Myokardia, Inc.
Drug timelines are a Plus or Pro feature.

30 regulatory and trial events tracked for CAMZYOS, covering 2017-03-22 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China

See pricing